# DCP Support- HPV16L1/RG1 Virus-Like Particle Vaccine

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2020 · $2,511

## Abstract

Initiate preclinical analysis of samples from experimental animals immunized with HPV16L1/RG1.  This preclinical work includes three mouse vaccination studies, ELISA validation and testing of mouse samples using antigens and materials needed to initiate L2 neutralization assay validation starting with 2 HPV types.

## Key facts

- **NIH application ID:** 10132911
- **Project number:** 261200800001E-P00156-9999-140
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** DAVID HEIMBROOK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $2,511
- **Award type:** —
- **Project period:** 2008-09-26 → 2019-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10132911

## Citation

> US National Institutes of Health, RePORTER application 10132911, DCP Support- HPV16L1/RG1 Virus-Like Particle Vaccine (261200800001E-P00156-9999-140). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10132911. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*